Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Blundell, John E
and
Finlayson, Graham
2004.
Is susceptibility to weight gain characterized by homeostatic or hedonic risk factors for overconsumption?.
Physiology & Behavior,
Vol. 82,
Issue. 1,
p.
21.
Harrold, Joanne
Pinkney, Jonathan
and
Williams, Gareth
2004.
Control of obesity through the regulation of appetite.
Drug Discovery Today: Therapeutic Strategies,
Vol. 1,
Issue. 2,
p.
219.
Haller, J.
Varga, B.
Ledent, C.
and
Freund, T. F.
2004.
CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.
Behavioural Pharmacology,
Vol. 15,
Issue. 4,
p.
299.
Cani, Patrice D.
Montoya, Maite Lasa
Neyrinck, Audrey M.
Delzenne, Nathalie M.
and
Lambert, Didier M.
2004.
Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide.
British Journal of Nutrition,
Vol. 92,
Issue. 5,
p.
757.
Gamber, Kevin M.
Macarthur, Heather
and
Westfall, Thomas C.
2005.
Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus.
Neuropharmacology,
Vol. 49,
Issue. 5,
p.
646.
Arch, Jonathan R. S.
2005.
Central regulation of energy balance: inputs, outputs and leptin resistance.
Proceedings of the Nutrition Society,
Vol. 64,
Issue. 1,
p.
39.
Hentges, Shane T.
Low, Malcolm J.
and
Williams, John T.
2005.
Differential Regulation of Synaptic Inputs by Constitutively Released Endocannabinoids and Exogenous Cannabinoids.
The Journal of Neuroscience,
Vol. 25,
Issue. 42,
p.
9746.
Sipe, J C
Waalen, J
Gerber, A
and
Beutler, E
2005.
Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH).
International Journal of Obesity,
Vol. 29,
Issue. 7,
p.
755.
Hillard, Cecilia J.
2005.
Lipids and drugs of abuse.
Life Sciences,
Vol. 77,
Issue. 14,
p.
1531.
Carai, Mauro A.M.
Colombo, Giancarlo
and
Gessa, Gian Luigi
2005.
Rimonabant: The first therapeutically relevant cannabinoid antagonist.
Life Sciences,
Vol. 77,
Issue. 19,
p.
2339.
Solinas, Marcello
and
Goldberg, Steven R
2005.
Motivational Effects of Cannabinoids and Opioids on Food Reinforcement Depend on Simultaneous Activation of Cannabinoid and Opioid Systems.
Neuropsychopharmacology,
Vol. 30,
Issue. 11,
p.
2035.
Trayhurn, Paul
2005.
The biology of obesity.
Proceedings of the Nutrition Society,
Vol. 64,
Issue. 1,
p.
31.
Marks, Daniel
2005.
Pharmacotherapy of Cachexia.
p.
491.
Fride, Ester
Bregman, Tatyana
and
Kirkham, Tim C.
2005.
Endocannabinoids and Food Intake: Newborn Suckling and Appetite Regulation in Adulthood.
Experimental Biology and Medicine,
Vol. 230,
Issue. 4,
p.
225.
Valverde, O.
Karsak, M.
and
Zimmer, A.
2005.
Cannabinoids.
Vol. 168,
Issue. ,
p.
117.
Tang, Stephanie L.
Tran, Vythao
and
Wagner, Edward J.
2005.
Sex Differences in the Cannabinoid Modulation of an A-Type K+ Current in Neurons of the Mammalian Hypothalamus.
Journal of Neurophysiology,
Vol. 94,
Issue. 4,
p.
2983.
Barth, Francis
2005.
Annual Reports in Medicinal Chemistry Volume 40.
Vol. 40,
Issue. ,
p.
103.
J??rbe, T. U. C.
and
DiPatrizio, N. V.
2005.
??9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist ??9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats.
Behavioural Pharmacology,
Vol. 16,
Issue. 5-6,
p.
373.
Hill, Matthew N.
and
Gorzalka, Boris B.
2005.
Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test.
European Neuropsychopharmacology,
Vol. 15,
Issue. 6,
p.
593.
Carpino, Philip A.
Griffith, David A.
Sakya, Subas
Dow, Robert L.
Black, Shawn C.
Hadcock, John R.
Iredale, Philip A.
Scott, Dennis O.
Fichtner, Michael W.
Rose, Colin R.
Day, Robert
Dibrino, Joseph
Butler, Mary
DeBartolo, Demetria B.
Dutcher, Darrin
Gautreau, Denise
Lizano, Jeff S.
O’Connor, Rebecca E.
Sands, Michelle A.
Kelly-Sullivan, Dawn
and
Ward, Karen M.
2006.
New bicyclic cannabinoid receptor-1 (CB1-R) antagonists.
Bioorganic & Medicinal Chemistry Letters,
Vol. 16,
Issue. 3,
p.
731.